Diese Webseite nutzt Cookies

Diese Webseite nutzt Cookies zur Verbesserung des Erlebnisses unserer Besucher. Indem Sie weiterhin auf dieser Webseite navigieren, erklären Sie sich mit unserer Verwendung von Cookies einverstanden.

Essenzielle Cookies ermöglichen grundlegende Funktionen und sind für die einwandfreie Funktion der Website erforderlich.
Statistik Cookies erfassen Informationen anonym. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing-Cookies werden von Drittanbietern oder Publishern verwendet, um personalisierte Werbung anzuzeigen. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen.

Welcome to the ITM Newsroom

Media contact

Press Releases

ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026

ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026

Read more
ITM Announces Phase 3 COMPETE Trial Post-Hoc Subgroup Analyses with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Pancreatic Neuroendocrine Tumors at ENETS 2026 Conference

ITM Announces Phase 3 COMPETE Trial Post-Hoc Subgroup Analyses with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Pancreatic Neuroendocrine Tumors at ENETS 2026 Conference

Read more
ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026

ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026

Read more
ITM to Present at the 44th Annual J.P. Morgan Healthcare Conference

ITM to Present at the 44th Annual J.P. Morgan Healthcare Conference

Read more
ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma

ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma

Read more
ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Read more
ITM to Participate in Upcoming Investor Conferences

ITM to Participate in Upcoming Investor Conferences

Read more
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Read more
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

Read more

Upcoming Events

ASCO 2026
29 May - 02 Jun 2026

ASCO 2026

29 May - 02 June
Chicago, IL, USA. Visit the ASCO Website.

SNMMI 2026
30 May - 02 Jun 2026

SNMMI 2026

30 May to 02 June. Visit the SNMMI Website.

More Info

ASTRO 2026
28 Sep - 01 Oct 2026

ASTRO 2026

ASTRO Annual Meeting - American Society for Radiation Oncology (ASTRO)
Sept 28 - Oct 1, Boston, Massachusetts. Visit the ASTRO Website.

EANM 2026
17 Oct - 21 Oct 2026

EANM 2026

17-21 October, Vienna, Austria

ESMO 2026
23 Oct - 27 Oct 2026

ESMO 2026

23-27 October, Madrid, Spain

SNMMI 2026
04 Nov - 07 Nov 2026

SNMMI 2026

Theranostics Conference
Nov 4-7, Bethesda, Maryland. Visit the SNMMI Website.

NANETS 2026
05 Nov - 07 Nov 2026

NANETS 2026

Multidisciplinary NET Medical Symposium
November 5-7, Las Vegas, Nevada. Visit the NANETS Website.

ITM Newsletter — Stay informed about our latest updates!

Subscribe here

Kathleen Noonan
Julia Westermeir

ITM Media Contact

Corporate Communications

Kathleen Noonan/Julia Westermeir

Phone: +49 89 329 8986 1500

E-Mail: communications@itm-radiopharma.com